Drugs Made In America Acquisition LLC — SEC Form 4 filings
SEC reporting owner CIK 2038492. 2 Form 4 filings on record with FilingPulse; latest filed 2025-02-18.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2025-02-04 to 2025-02-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 430,000 shares.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,698,363 shares.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition Corp. (DMAA) | 10% owner | 2 | 2 legs · 430,000 sh | 1 leg · 5,698,363 sh | 3 |
Form 4 filings — Drugs Made In America Acquisition LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-18 | 4 | Drugs Made In America Acquisition Corp. (DMAA) | Purchase (P): 30,000 · Purchase (P): 30,000 (derivative) | EDGAR |
| 2025-02-04 | 4 | Drugs Made In America Acquisition Corp. (DMAA) | Purchase (P): 400,000 · Other (J): 400,000 · Sale (S): 5,698,363 · Purchase (P): 400,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2038492 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →